Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Camzyos
Pharma
Cytokinetics scores its first FDA nod with Myqorzo approval
The FDA has signed off on Cytokinetics’ potential blockbuster hypertrophic cardiomyopathy (oHCM) treatment Myqorzo.
Kevin Dunleavy
Dec 22, 2025 12:05pm
Fierce Biotech
Cytokinetics doesn't want Big Pharma help to overtake Camzyos
Nov 18, 2025 1:30pm
BMS' Camzyos falls short in bid to widen eligible patient pool
Apr 15, 2025 11:42am
BMS runs first branded TV spot for $13B heart disease drug
Feb 2, 2024 7:45am
Merck-Daiichi, Kelun, AstraZeneca—Fierce Pharma Asia
Oct 27, 2023 9:10am
Bristol's Camyzos picks up early nod from England's NICE
Jun 2, 2023 11:04am
